| Application no. and date | 04760694.2 (espacenet) (Federated) (European Patent Register), 20040430 | | Patent/reg. no. and date | DK/EP 1620133, 20151209 | | Publication date | 20060201 | | Priority no. and date | US 467195 P, 20030501, US 475726 P, 20030604 | | EP pub. no. and date |
EP 1620133 20060201 | | Effective date | | | Applicant/owner | GENZYME CORPORATION, 500 Kendall Street
Cambridge, MA 02142, US | | Applicant ref. no. | Sanofi 5262EP | | Inventor | DODGE, James, 1 Gates Circle
Worcester, MA 01603, US,
PASSINI, Marco, A., 14 Nightingale Drive
Shrewsbury, Massachusetts 01545, US,
STEWART, Gregory R., 4735 Xene Lane South
Plymouth, Minnesota 55446, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 48/00 (2006.01) | | Title | GENTERAPI TIL NEUROMETABOLISKE SYGDOMME | | Int. application no. | US2004013685 | | Int. publication no. | WO2004098648 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
